Post date January 20, 2023 Experience iQIYI $442 million follow-on offering We advised the issuer on a follow-on offering of ADSs
Post date January 18, 2023 Experience New Horizon Health HK$781.7 million top-up placement of shares We advised New Horizon Health on the top-up placement
Post date January 18, 2023 Experience Jinxin Fertility Group HK$1.17 billion top-up placement of shares The shares are listed on the Hong Kong Stock Exchange
Post date January 12, 2023 Experience Bilibili convertible notes exchange and concurrent follow-on equity offering The transaction involved a convertible notes exchange and a concurrent follow-on offering of ADSs
Post date January 3, 2023 Experience Kingsoft Cloud dual primary listing on the Hong Kong Stock Exchange We advised Kingsoft Cloud on its dual primary listing by way of introduction on the HKEX
Post date December 2, 2022 Experience Xiamen ITG $200 million bonds offering The 6.5% guaranteed bonds are due 2023
Post date November 14, 2022 Experience Atour Lifestyle Holdings $52 million IPO We advised Atour on its IPO and Nasdaq listing
Post date October 26, 2022 Experience DFZQ $300 million bonds offering The investment-grade bonds are due 2025
Post date September 22, 2022 Experience InnoCare Pharma RMB2.9 billion Shanghai IPO This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far
Post date September 21, 2022 Experience Tencent Music Entertainment Group secondary listing We advised Tencent Music Entertainment Group on its secondary listing by way of introduction on the HKEX